190 related articles for article (PubMed ID: 32740043)
21. The incidence of second primary tumors in thyroid cancer patients is increased, but not related to treatment of thyroid cancer.
Verkooijen RB; Smit JW; Romijn JA; Stokkel MP
Eur J Endocrinol; 2006 Dec; 155(6):801-6. PubMed ID: 17132748
[TBL] [Abstract][Full Text] [Related]
22. The impact of BMI on clinical progress, response to treatment, and disease course in patients with differentiated thyroid cancer.
Gąsior-Perczak D; Pałyga I; Szymonek M; Kowalik A; Walczyk A; Kopczyński J; Lizis-Kolus K; Trybek T; Mikina E; Szyska-Skrobot D; Gadawska-Juszczyk K; Hurej S; Szczodry A; Słuszniak A; Słuszniak J; Mężyk R; Góźdź S; Kowalska A
PLoS One; 2018; 13(10):e0204668. PubMed ID: 30273371
[TBL] [Abstract][Full Text] [Related]
23. Comment on: Lack of association between obesity and aggressiveness of differentiated thyroid cancer.
Campennì A; Trimarchi F; Baldari S
J Endocrinol Invest; 2019 Jan; 42(1):107-108. PubMed ID: 30343357
[No Abstract] [Full Text] [Related]
24. Trends in pediatric thyroid cancer incidence in the United States, 1998-2013.
Bernier MO; Withrow DR; Berrington de Gonzalez A; Lam CJK; Linet MS; Kitahara CM; Shiels MS
Cancer; 2019 Jul; 125(14):2497-2505. PubMed ID: 31012956
[TBL] [Abstract][Full Text] [Related]
25. Pregnancy as a risk factor for thyroid cancer progression.
Rakhlin L; Fish S
Curr Opin Endocrinol Diabetes Obes; 2018 Oct; 25(5):326-329. PubMed ID: 29965867
[TBL] [Abstract][Full Text] [Related]
26. The association between multinodular goiter and thyroid cancer.
Verburg FA; Reiners C
Minerva Endocrinol; 2010 Sep; 35(3):187-92. PubMed ID: 20938421
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of STAT3 activity delays obesity-induced thyroid carcinogenesis in a mouse model.
Park JW; Han CR; Zhao L; Willingham MC; Cheng SY
Endocr Relat Cancer; 2016 Jan; 23(1):53-63. PubMed ID: 26552408
[TBL] [Abstract][Full Text] [Related]
28. Role of hemithyroidectomy in differentiated thyroid cancer.
Gibelli B; Dionisio R; Ansarin M
Curr Opin Otolaryngol Head Neck Surg; 2015 Apr; 23(2):99-106. PubMed ID: 25692624
[TBL] [Abstract][Full Text] [Related]
29. Attributable risk fraction of four lifestyle risk factors of thyroid cancer: a meta-analysis.
Sadeghi H; Rafei M; Bahrami M; Haghdoost A; Shabani Y
J Public Health (Oxf); 2018 Jun; 40(2):e91-e98. PubMed ID: 28977647
[TBL] [Abstract][Full Text] [Related]
30. Decreased staging of differentiated thyroid cancer in patients with chronic lymphocytic thyroiditis.
Borowczyk M; Janicki A; Dworacki G; Szczepanek-Parulska E; Danieluk M; Barnett J; Antonik M; Kałużna M; Bromińska B; Czepczyński R; Bączyk M; Ziemnicka K; Ruchała M
J Endocrinol Invest; 2019 Jan; 42(1):45-52. PubMed ID: 29619749
[TBL] [Abstract][Full Text] [Related]
31. Risk factors in thyroid cancer: is the obesity pandemic an important factor?
Matrone A
Expert Rev Endocrinol Metab; 2022 Nov; 17(6):463-466. PubMed ID: 36345844
[No Abstract] [Full Text] [Related]
32. Anthropometric Risk Factors for Differentiated Thyroid Cancer in Young Men and Women From Eastern France: A Case-Control Study.
Xhaard C; de Vathaire F; Cléro E; Maillard S; Ren Y; Borson-Chazot F; Sassolas G; Schvartz C; Colonna M; Lacour B; Danzon A; Velten M; Marrer E; Bailly L; Barjoan EM; Schlumberger M; Orgiazzi J; Adjadj E; Rubino C
Am J Epidemiol; 2015 Aug; 182(3):202-14. PubMed ID: 26133374
[TBL] [Abstract][Full Text] [Related]
33. Is malignant nodule topography an additional risk factor for metastatic disease in low-risk differentiated thyroid cancer?
Campennì A; Giovanella L; Siracusa M; Stipo ME; Alibrandi A; Cucinotta M; Ruggeri RM; Baldari S
Thyroid; 2014 Nov; 24(11):1607-11. PubMed ID: 25089829
[TBL] [Abstract][Full Text] [Related]
34. FOXE1 Polymorphism Interacts with Dietary Iodine Intake in Differentiated Thyroid Cancer Risk in the Cuban Population.
Ren Y; Lence-Anta JJ; Pereda CM; Chappe M; Velasco M; Infante I; Bustillo M; Turcios S; Leufroy A; Guérin T; Noël L; Lesueur F; Maillard S; Cléro E; Xhaard C; Allodji RS; Rubino C; Rodriguez R; Ortiz RM; de Vathaire F
Thyroid; 2016 Dec; 26(12):1752-1760. PubMed ID: 27610545
[TBL] [Abstract][Full Text] [Related]
35. Risk factors for venous thromboembolism in patients treated for differentiated thyroid carcinoma.
van der Boom T; Klein Hesselink EN; Kooistra HAM; Meijer K; van der Horst-Schrivers ANA; Lefrandt JD; Links TP
Endocr Relat Cancer; 2017 Jun; 24(6):267-273. PubMed ID: 28476911
[TBL] [Abstract][Full Text] [Related]
36. Novel genome-wide association study-based candidate loci for differentiated thyroid cancer risk.
Figlioli G; Köhler A; Chen B; Elisei R; Romei C; Cipollini M; Cristaudo A; Bambi F; Paolicchi E; Hoffmann P; Herms S; Kalemba M; Kula D; Pastor S; Marcos R; Velázquez A; Jarząb B; Landi S; Hemminki K; Försti A; Gemignani F
J Clin Endocrinol Metab; 2014 Oct; 99(10):E2084-92. PubMed ID: 25029422
[TBL] [Abstract][Full Text] [Related]
37. Adiposity and risk of thyroid cancer: a systematic review and meta-analysis.
Schmid D; Ricci C; Behrens G; Leitzmann MF
Obes Rev; 2015 Dec; 16(12):1042-54. PubMed ID: 26365757
[TBL] [Abstract][Full Text] [Related]
38. Nutritional status and follicular-derived thyroid cancer: An update.
Barrea L; Gallo M; Ruggeri RM; Giacinto PD; Sesti F; Prinzi N; Adinolfi V; Barucca V; Renzelli V; Muscogiuri G; Colao A; Baldelli R;
Crit Rev Food Sci Nutr; 2021; 61(1):25-59. PubMed ID: 31997660
[TBL] [Abstract][Full Text] [Related]
39. Multiple primary tumors in differentiated thyroid carcinoma and relationship to thyroid cancer outcome.
Omür O; Ozcan Z; Yazici B; Akgün A; Oral A; Ozkiliç H
Endocr J; 2008 May; 55(2):365-72. PubMed ID: 18277003
[TBL] [Abstract][Full Text] [Related]
40. Death from thyroid cancer of follicular cell origin.
Wu HS; Young MT; Ituarte PH; D'Avanzo A; Duh QY; Greenspan FS; Loh KC; Clark OH
J Am Coll Surg; 2000 Dec; 191(6):600-6. PubMed ID: 11129807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
